Assembly Biosciences, Inc.

NASDAQ:ASMB

Biotechnology

Healthcare
$22.39 +0.66%

+$0.16 today

Market cap
$458.48M
Beta
1.08
P/E (TTM)
-64.4
EPS (TTM)
-$0.38
52W Low $16.50High $39.71

Volume 0.49M

Average 0.17M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$41.09M

FY 2025 · Annual

Investing Cash Flow

-$113.47M

FY 2025 · Annual

Financing Cash Flow

$174.67M

FY 2025 · Annual

+493.1% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(129.86M)(93.09M)(61.23M)(40.18M)(6.12M)
Depreciation & Amortization466K498K450K129K129K
Deferred Income Tax(2.53M)0000
Stock-Based Compensation5.24M6.59M5.12M3.12M4.68M
Change in Working Capital(11.4M)(2.12M)76.34M(11.95M)(38.28M)
Accounts Receivables894K(608K)901K43K(974K)
Inventory00000
Accounts Payables(1.94M)(166K)(2.03M)124K586K
Other Working Capital(10.36M)(1.35M)77.47M(12.12M)(37.89M)
Other Non-Cash Items44.69M3.66M2.06M(2.24M)(1.5M)
Operating Cash Flow(93.4M)(84.46M)22.74M(51.12M)(41.09M)
Capital Expenditures(3.1M)(102K)(255K)(28K)(66K)
Acquisitions (Net)1.5M1.5M000
Purchases of Investments(160.45M)(27.58M)(133.92M)(90.5M)(232.18M)
Sales of Investments187.7M116.83M65.02M130.7M116.43M
Other Investing Activities857K024K02.35M
Investing Cash Flow26.52M90.64M(69.14M)40.17M(113.47M)
Debt Repayment00000
Common Stock Issued52.81M325K13.69M29.29M174.67M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities258K289K129K155K0
Financing Cash Flow53.06M614K13.82M29.45M174.67M
Effect of Forex Changes00000
Net Change in Cash(13.82M)6.79M(32.58M)18.5M20.11M
Free Cash Flow(96.49M)(84.57M)22.49M(51.15M)(41.16M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$6.1M
+ D&A$129.0K
+ Stock-Based Comp$4.7M
+ Deferred Tax$0
- Working Capital-$38.3M
- Other Non-Cash-$1.5M
= Operating Cash Flow-$41.1M
- Capex-$66.0K
= Free Cash Flow-$41.2M

Analysis

FY2025 free cash flow is -$41.2M. FCF conversion is 672.3% of net income. Operating cash flow was -$41.1M, with capex of -$66.0K. The largest bridge item is Working Capital at -$38.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026
4Statement of changes in beneficial ownershipNov 3, 2026

Does ASMB generate free cash flow?

Assembly Biosciences, Inc. (ASMB) generated -$41.16M of free cash flow in fiscal 2025.

How much operating cash flow does ASMB produce?

Operating cash flow was -$41.09M, before capital expenditures of $66,000.00.